MAPT and Alzheimer disease: In AD, cerebrospinal fluid (CSF) amyloid beta (Aβ)1–42 and Aβ1–42/Aβ1–40 ratio are reduced, and total tau/Aβ1–42 ratio and phosphorylated tau (p-tau) both elevated [2].